A chemical used to help treat diseased kidneys has plaintiffs lawyers salivating at the thought of a new arena of billion-dollar mass torts, but one San Francisco firm wants to take it one suit at a time.
“I think the work that we do [in the first case] will set the tone for other cases; and of course we’re hoping to get other cases as well,” said Jeffrey Kaiser, a partner at Levin Simes Kaiser & Gornick.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
